Search Page

1

Cite

Share

Public funding for transformative drugs: the case of sofosbuvir.

Barenie RE, Avorn J, Tessema FA, Kesselheim AS. Barenie RE, et al. Among authors: tessema fa. Drug Discov Today. 2021 Jan;26(1):273-281. doi: 10.1016/j.drudis.2020.09.024. Epub 2020 Oct 1. Drug Discov Today. 2021. PMID: 33011345 Free PMC article. Review.

Cite

Share

2

Cite

Share

Physician Perceptions of Step Therapy Prescribing Requirements.

Fischer MA, Kesselheim AS, Lu Z, Ross KM, Tessema FA, Avorn J. Fischer MA, et al. Among authors: tessema fa. J Manag Care Spec Pharm. 2019 Nov;25(11):1210-1224. doi: 10.18553/jmcp.2019.25.11.1210. J Manag Care Spec Pharm. 2019. PMID: 31663459

Cite

Share

3

Cite

Share

Challenges and Opportunities for Biomarker Validation.

Hey SP, D'Andrea E, Jung EH, Tessema F, Luo J, Gyawali B, Kesselheim AS. Hey SP, et al. Among authors: tessema f. J Law Med Ethics. 2019 Sep;47(3):357-361. doi: 10.1177/1073110519876162. J Law Med Ethics. 2019. PMID: 31560620

Cite

Share

4

Cite

Share

Generic Competition for Drugs Treating Rare Diseases.

Beall RF, Quinn AE, Kesselheim AS, Tessema FA, Sarpatwari A. Beall RF, et al. Among authors: tessema fa. J Law Med Ethics. 2020 Dec;48(4):789-795. doi: 10.1177/1073110520979391. J Law Med Ethics. 2020. PMID: 33404340 No abstract available.

Cite

Share

5

Cite

Share

Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.

Sarpatwari A, He M, Tessema FA, Gagne JJ, Kesselheim AS. Sarpatwari A, et al. Among authors: tessema fa. Drug Saf. 2021 Mar;44(3):327-335. doi: 10.1007/s40264-020-01017-z. Epub 2020 Nov 18. Drug Saf. 2021. PMID: 33206339

Cite

Share

6

Cite

Share

Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM. Kesselheim AS, et al. Among authors: tessema fa. JAMA Intern Med. 2019 May 1;179(5):707-709. doi: 10.1001/jamainternmed.2018.8121. JAMA Intern Med. 2019. PMID: 30667474 Free PMC article.

Cite

Share

7

Cite

Share

Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition Unclear.

Sarpatwari A, Tessema FA, Zakarian M, Najafzadeh MN, Kesselheim AS. Sarpatwari A, et al. Among authors: tessema fa. Health Aff (Millwood). 2021 May;40(5):772-778. doi: 10.1377/hlthaff.2020.01436. Health Aff (Millwood). 2021. PMID: 33939506

Cite

Share

8

Cite

Share

US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.

Rome BN, Tessema FA, Kesselheim AS. Rome BN, et al. Among authors: tessema fa. JAMA Intern Med. 2020 Sep 1;180(9):1165-1172. doi: 10.1001/jamainternmed.2020.2771. JAMA Intern Med. 2020. PMID: 32897384 Free PMC article.

Cite

Share

9

Cite

Share

Internal Medicine Physicians' Financial Relationships with Industry: An Updated National Estimate.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM. Kesselheim AS, et al. Among authors: tessema fa. J Gen Intern Med. 2019 Feb;34(2):195-197. doi: 10.1007/s11606-018-4688-z. J Gen Intern Med. 2019. PMID: 30291605 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

A New Approach to Treat Childhood Leukemia: Novartis' CAR-T Therapy.

Tessema FA, Darrow JJ. Tessema FA, et al. J Law Med Ethics. 2017 Dec;45(4):692-697. doi: 10.1177/1073110517750609. J Law Med Ethics. 2017. PMID: 30027797 No abstract available.

Cite

Share